Share-based Payment Arrangement, Expense of Harvard Apparatus Regenerative Technology, Inc. from 30 Sep 2012 to 30 Sep 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Harvard Apparatus Regenerative Technology, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Sep 2012 to 30 Sep 2024.
  • Harvard Apparatus Regenerative Technology, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2024 was $562,000, a 5% increase year-over-year.
  • Harvard Apparatus Regenerative Technology, Inc. annual Share-based Payment Arrangement, Expense for 2020 was $70,000, a 96% decline from 2019.
  • Harvard Apparatus Regenerative Technology, Inc. annual Share-based Payment Arrangement, Expense for 2019 was $1,654,000, a 119% increase from 2018.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Harvard Apparatus Regenerative Technology, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $562,000 +$27,000 +5% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 $572,000 +$93,000 +19% 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 $560,000 -$1,280,000 -70% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2024 2024 Q1
Q3 2023 $535,000 +$291,000 +119% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024 2024 Q3
Q2 2023 $479,000 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024 2024 Q2
Q1 2023 $1,840,000 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024 2024 Q1
Q3 2022 $244,000 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023 2023 Q3
Q2 2021 $522,000 $131,000 -$134,000 -51% 01 Apr 2021 30 Jun 2021 10-Q 13 Aug 2021 2021 Q2
Q1 2021 $388,000 $130,000 -$458,000 -78% 01 Jan 2021 31 Mar 2021 10-Q 24 May 2021 2021 Q1
Q4 2020 $70,000 $934,000 +$60,234,000 +98% 01 Oct 2020 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q3 2020 $60,164,000 $151,000 -$378,000 -71% 01 Jul 2020 30 Sep 2020 10-Q 13 Nov 2020 2020 Q3
Q2 2020 $59,786,000 $265,000 -$61,735,000 -100% 01 Apr 2020 30 Jun 2020 10-Q 13 Aug 2021 2021 Q2
Q1 2020 $71,361,000 $588,000 +$295,000 +101% 01 Jan 2020 31 Mar 2020 10-Q 24 May 2021 2021 Q1
Q1 2020 $70,000,000 +$69,707,000 +23791% 01 Feb 2020 29 Feb 2020 10-Q 13 Aug 2021 2021 Q2
Q4 2019 $1,654,000 $61,168,000 -$61,462,000 -20905% 01 Oct 2019 31 Dec 2019 10-K 13 Apr 2021 2020 FY
Q3 2019 $63,116,000 $529,000 +$335,000 +173% 01 Jul 2019 30 Sep 2019 10-Q 13 Nov 2020 2020 Q3
Q2 2019 $62,000,000 +$61,808,000 +32192% 01 Jun 2019 30 Jun 2019 10-K 13 Apr 2021 2020 FY
Q2 2019 $62,781,000 $531,000 +$339,000 +177% 01 Apr 2019 30 Jun 2019 10-Q 13 Aug 2020 2020 Q2
Q1 2019 $973,000 $293,000 +$218,000 +291% 01 Jan 2019 31 Mar 2019 10-Q 14 May 2020 2020 Q1
Q4 2018 $755,000 $294,000 01 Oct 2018 31 Dec 2018 10-K 27 Mar 2020 2019 FY
Q3 2018 $194,000 $0 0% 01 Jul 2018 30 Sep 2018 10-Q 13 Nov 2019 2019 Q3
Q2 2018 $192,000 -$14,000 -6.8% 01 Apr 2018 30 Jun 2018 10-Q 13 Aug 2019 2019 Q2
Q1 2018 $75,000 -$116,000 -61% 01 Jan 2018 31 Mar 2018 10-Q 14 May 2019 2019 Q1
Q3 2017 $194,000 01 Jul 2017 30 Sep 2017 10-Q 09 Nov 2018 2018 Q3
Q2 2017 $206,000 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2018 2018 Q2
Q1 2017 $191,000 01 Jan 2017 31 Mar 2017 10-Q 11 May 2018 2018 Q1
Q3 2013 $220,000 +$64,000 +41% 01 Jul 2013 30 Sep 2013 10-Q 27 Nov 2013 2013 Q3
Q3 2012 $156,000 01 Jul 2012 30 Sep 2012 10-Q 27 Nov 2013 2013 Q3

Harvard Apparatus Regenerative Technology, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2020 $70,000 -$1,584,000 -96% 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022 2021 FY
2019 $1,654,000 +$899,000 +119% 01 Jan 2019 31 Dec 2019 10-K 13 Apr 2021 2020 FY
2018 $755,000 01 Jan 2018 31 Dec 2018 10-K 27 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.